Recombinant Human Erythropoietin (Zhejiang Chinagene Biopharmaceutical)

N/A

Report date: 2025/01/26 16:57:26

Base Information

Drug NameRecombinant Human Erythropoietin (Zhejiang Chinagene Biopharmaceutical)
Drug Alias NamerhEPO (Zhejiang Chinagene Biopharmaceutica)erythropoietinepoetin
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang Zhongqi Biological Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Zhongqi Biological Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAnemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A